
LMAT • NASDAQ
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold LMAT in your mock portfolio yet.
With EPS of 2.32 and a PE ratio of 36.78, LeMaitre Vascular is priced as a quality, growth-oriented medtech name, but not cheaply. The valuation implies investors expect continued earnings expansion, yet the information provided does not indicate an obvious near-term acceleration or deterioration in fundamentals. Overall, the setup looks balanced: solid profitability but a valuation that already embeds optimistic expectations.
The stock trades at $85.33, slightly below its 200-day moving average of $86.35, and is up 2.8% over the last month, indicating a modest positive drift but not a strong uptrend. An RSI of 44.98 is in the middle of the range, suggesting neither overbought nor oversold conditions. Overall, technicals point to a consolidating stock with no strong directional signal.
Alternative data points are weak to slightly negative: web traffic is modest at ~14.9k monthly visitors, social media followings are very small and largely stagnant, and job postings have dropped to zero. The sharp decline in job openings, in particular, can be an early sign of cautious management behavior or slower growth initiatives. Collectively, these signals lean more cautious than supportive of a strong growth narrative.
LeMaitre Vascular’s stock currently reflects a reasonably profitable, niche medtech company valued at a growth multiple, but without strong confirming signals from technicals or alternative data. The price action and RSI are neutral, while hiring and digital engagement trends are soft, tempering the otherwise solid earnings profile implied by the PE and EPS. Overall, the balance of signals points to a neutral outlook, with upside dependent on the company delivering continued growth to justify its valuation.


Final Trade: LMAT, REGN, BA, TJX

LeMaitre to Participate in Upcoming Investor Conferences
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: